Brittenham Marissa
- SEC CIK
- 0001908044
In the past year, 2 open-market sale filings worth $166.2K and no purchases.
Current role at each company
- SGRY Surgery Partners, Inc.Chief Strategy Officeras of Mar 16, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $166.2K
- 2 filings
- Net
- −$166.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brittenham Marissa as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 (view filing) | Mar 13 | 3 days | Brittenham MarissaChief Strategy Officer | SSale | −3.66K | $12.54 | −$45.9K | −3.7%94.2K after | |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | Brittenham MarissaChief Strategy Officer | SSale | −8.79K | $13.70 | −$120.4K | −13.9%54.6K after | |
| Mar 13, 2025 (view filing) | Mar 10 | 3 daysLate | Brittenham MarissaChief Strategy Officer | SSale | −3.16K | $24.09 | −$76.0K | −4.7%63.4K after | |
| Feb 10, 2025 (view filing) | Feb 7 | 3 days | Brittenham MarissaChief Strategy Officer | SSale | −14.7K | $25.61 | −$376.5K | −22.7%50.2K after | |
| Mar 6, 2024 (view filing) | Mar 4 | 2 days | Brittenham MarissaChief Strategy Officer | SSale | −1.28K | $30.17 | −$38.7K | −3.1%39.8K after | |
| Feb 6, 2024 (view filing) | Feb 2 | 4 days | Brittenham MarissaChief Strategy Officer | SSale | −1.64K | $31.89 | −$52.2K | −5.1%30.5K after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Brittenham MarissaChief Strategy Officer | SSale | −1.32K | $35.90 | −$47.4K | −12.5%9.28K after |